Organon & Co.
For the period ended Sep 30, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 10, 2025
OGN$13.85-0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(Unaudited, $ in millions except shares in thousands and per share amounts)
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $672 | $675 |
| Accounts receivable (net of allowance for doubtful accounts of $12 in 2025 and $14 in 2024) | 1,484 | 1,358 |
| Inventories (excludes inventories of $247 in 2025 and $215 in 2024 classified in Other assets) | 1,488 | 1,321 |
| Other current assets | 1,056 | 994 |
| Total Current Assets | 4,700 | 4,348 |
| Property, plant and equipment, net | 1,290 | 1,168 |
| Goodwill | 4,680 | 4,680 |
| Intangibles, net | 1,340 | 1,414 |
| Other assets | 1,542 | 1,491 |
| Total Assets | $13,552 | $13,101 |
| Liabilities and Equity | ||
| Current Liabilities: | ||
| Current portion of long-term debt and short-term borrowings | $45 | $20 |
| Trade accounts payable | 1,074 | 1,153 |
| Accrued and other current liabilities | 1,444 | 1,411 |
| Income taxes payable | 116 | 134 |
| Total Current Liabilities | 2,679 | 2,718 |
| Long-term debt | 8,783 | 8,860 |
| Deferred income taxes | 62 | 74 |
| Other noncurrent liabilities | 1,122 | 977 |
| Total Liabilities | 12,646 | 12,629 |
| Contingencies (Note 15) | ||
| Organon & Co. Stockholders’ Equity: | ||
| Common stock, $0.01 par valueAuthorized - 500,000Issued and outstanding - 259,983 in 2025 and 257,799 in 2024 | 3 | 3 |
| Additional paid-in capital | 159 | 108 |
| Retained earnings | 1,318 | 1,010 |
| Accumulated other comprehensive loss | (574) | (649) |
| Total Stockholders’ Equity | 906 | 472 |
| Total Liabilities and Stockholders’ Equity | $13,552 | $13,101 |
-5-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.